Ellisiv Mathiesen on tenecteplase for patients with wake-up stroke

The Lancet Neurology in conversation with

English - January 19, 2023 23:00 - 8 minutes - 6.05 MB
Life Sciences Science Education stroke alzheimer's epilepsy sleep cerebral multiple sclerosis Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: Beau Ances on amyloid biomarkers in Alzheimer’s

Next Episode: Geraldine Dawson on advances in the prediction of autism during infancy

Ellisiv Mathiesen (The University of Tromsø – the Arctic University of Norway, Tromsø, Norway) discusses the findings of the TWIST trial, which investigated the use of tenecteplase for patients with wake-up stroke who were selected for treatment by non-contrast CT. This Fast-track Article is published in the February issue of The Lancet Neurology.

Read the full article:
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST)

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv